Phase 2/3, Children and Adolescents With Aquaporin-4 antibody Positive (AQP4-Ab [+]) Neuromyelitis Optica Spectrum Disorder (NMOSD)
Clinical Trial Grant
Administered By
Pediatrics, Rheumatology
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
March 21, 2024
End Date
December 20, 2026
Administered By
Pediatrics, Rheumatology
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
March 21, 2024
End Date
December 20, 2026